MENU
+Compare
ENVB
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$1.36
Change
-$0.01 (-0.73%)
Capitalization
2.61M

ENVB Enveric Biosciences Inc Forecast, Technical & Fundamental Analysis

a provider of technology management solutions services

Industry Biotechnology
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for ENVB with price predictions
Feb 21, 2025

Momentum Indicator for ENVB turns negative, indicating new downward trend

ENVB saw its Momentum Indicator move below the 0 level on January 16, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 92 similar instances where the indicator turned negative. In of the 92 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day moving average for ENVB crossed bearishly below the 50-day moving average on January 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENVB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENVB entered a downward trend on February 21, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for ENVB just turned positive on February 20, 2025. Looking at past instances where ENVB's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENVB advanced for three days, in of 184 cases, the price rose further within the following month. The odds of a continued upward trend are .

ENVB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.662) is normal, around the industry mean (12.481). P/E Ratio (0.000) is within average values for comparable stocks, (84.446). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.603). ENVB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (0.000) is also within normal values, averaging (251.221).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ENVB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENVB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ENVB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ENVB is expected to report earnings to rise 66.67% to -40 cents per share on March 27

Enveric Biosciences Inc ENVB Stock Earnings Reports
Q4'24
Est.
$-0.40
Q3'24
Beat
by $0.28
Q2'24
Beat
by $0.24
Q1'24
Beat
by $0.16
Q4'23
Beat
by $0.12
The last earnings report on November 15 showed earnings per share of -23 cents, beating the estimate of -51 cents. With 207.03K shares outstanding, the current market capitalization sits at 2.61M.
A.I. Advisor
published General Information

General Information

a provider of technology management solutions services

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Electronics Or Appliances
Address
4851 Tamiami Trail N
Phone
+1 239 302-1707
Employees
7
Web
https://www.enveric.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CNK27.45-0.34
-1.22%
Cinemark Holdings
ASND152.43-2.15
-1.39%
Ascendis Pharma A/S
KVHI5.84-0.10
-1.68%
KVH Industries
REVB4.31-0.09
-2.05%
Revelation Biosciences Inc
IBCP33.49-1.05
-3.04%
Independent Bank Corp

ENVB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ENVB has been loosely correlated with PRQR. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ENVB jumps, then PRQR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENVB
1D Price
Change %
ENVB100%
-0.73%
PRQR - ENVB
43%
Loosely correlated
-0.78%
ALNY - ENVB
36%
Loosely correlated
-0.16%
ORMP - ENVB
33%
Poorly correlated
-3.15%
SLNCF - ENVB
28%
Poorly correlated
N/A
CDXS - ENVB
28%
Poorly correlated
-1.88%
More